Abciximab [abciximab]

topical
14
Terms

Reopro
ReoPro

 

c7E3 Fab
CentoRx
Chimeric 7E3 Fab
Clotinab
ReoPro

Definition

A Fab fragment of the chimeric monoclonal antibody 7E3 that binds to the glycoprotein IIb-IIIa receptor of human platelets, and blocks PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX, potently inhibiting PLATELET AGGREGATION. It is used in treatment of refractory unstable angina, and for prevention of ischemic complications in patients undergoing percutaneous coronary procedures such as ANGIOPLASTY; ATHERECTOMY; or stenting.

DUI
D000077284 MeSH Browser
CUI
M0227707
History note
2019 (1994)
Public note
2019; ABCIXIMAB was indexed under ANTIBODIES, MONOCLONAL and IMMUNOGLOBULIN FAB FRAGMENTS 1994-2018

D Chemicals and Drugs
D12.644 Peptides 1 380
D12.644.541 Peptide Fragments 357
D12.644.541.500 Immunoglobulin Fragments 187
D12.644.541.500.650 Immunoglobulin Fab Fragments 65
D12.644.541.500.650.125 Abciximab 14
D12.644.541.500.650.250 Certolizumab Pegol 47
D12.644.541.500.650.500 Immunoglobulin Variable Region 36
D12.644.541.500.650.750 Tuftsin 5
D12.776 Proteins 2 575
D12.776.124 Blood Proteins 909
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 486
D12.776.124.486.485.114 Antibodies 1 815
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 626
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 783
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 346
D12.776.124.486.485.114.224.060.313 Alemtuzumab 123
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 445
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 40
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 47
D12.776.124.486.485.114.224.060.750 Cetuximab 185
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 150
D12.776.124.486.485.114.224.060.790 Gemtuzumab 16
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 11
D12.776.124.486.485.114.224.060.798 Ipilimumab 253
D12.776.124.486.485.114.224.060.813 Natalizumab 156
D12.776.124.486.485.114.224.060.829 Nivolumab 427
D12.776.124.486.485.114.224.060.844 Omalizumab 112
D12.776.124.486.485.114.224.060.860 Palivizumab 12
D12.776.124.486.485.114.224.060.864 Panitumumab 57
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 61
D12.776.124.486.485.114.224.060.875 Trastuzumab 268
D12.776.124.486.485.114.224.060.937 Ustekinumab 120
D12.776.124.486.485.680 Immunoglobulin Fragments 187
D12.776.124.486.485.680.650 Immunoglobulin Fab Fragments 65
D12.776.124.486.485.680.650.125 Abciximab 14
D12.776.124.486.485.680.650.250 Certolizumab Pegol 47
D12.776.124.486.485.680.650.500 Immunoglobulin Variable Region 36
D12.776.124.486.485.680.650.750 Tuftsin 5
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 486
D12.776.124.790.651.114 Antibodies 1 815
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 626
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 783
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 346
D12.776.124.790.651.114.224.060.375 Alemtuzumab 123
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 445
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 40
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 47
D12.776.124.790.651.114.224.060.750 Cetuximab 185
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 150
D12.776.124.790.651.114.224.060.790 Gemtuzumab 16
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 11
D12.776.124.790.651.114.224.060.798 Ipilimumab 253
D12.776.124.790.651.114.224.060.813 Natalizumab 156
D12.776.124.790.651.114.224.060.829 Nivolumab 427
D12.776.124.790.651.114.224.060.844 Omalizumab 112
D12.776.124.790.651.114.224.060.860 Palivizumab 12
D12.776.124.790.651.114.224.060.864 Panitumumab 57
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 61
D12.776.124.790.651.114.224.060.875 Trastuzumab 268
D12.776.124.790.651.114.224.060.937 Ustekinumab 120
D12.776.124.790.651.680 Immunoglobulin Fragments 187
D12.776.124.790.651.680.650 Immunoglobulin Fab Fragments 65
D12.776.124.790.651.680.650.125 Abciximab 14
D12.776.124.790.651.680.650.250 Certolizumab Pegol 47
D12.776.124.790.651.680.650.500 Immunoglobulin Variable Region 36
D12.776.124.790.651.680.650.750 Tuftsin 5
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 486
D12.776.377.715.548.114 Antibodies 1 815
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 626
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 783
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 346
D12.776.377.715.548.114.224.200.375 Alemtuzumab 123
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 445
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 40
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 47
D12.776.377.715.548.114.224.200.750 Cetuximab 185
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 150
D12.776.377.715.548.114.224.200.790 Gemtuzumab 16
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 11
D12.776.377.715.548.114.224.200.798 Ipilimumab 253
D12.776.377.715.548.114.224.200.813 Natalizumab 156
D12.776.377.715.548.114.224.200.829 Nivolumab 427
D12.776.377.715.548.114.224.200.844 Omalizumab 112
D12.776.377.715.548.114.224.200.860 Palivizumab 12
D12.776.377.715.548.114.224.200.864 Panitumumab 57
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 61
D12.776.377.715.548.114.224.200.875 Trastuzumab 268
D12.776.377.715.548.114.224.200.937 Ustekinumab 120
D12.776.377.715.548.680 Immunoglobulin Fragments 187
D12.776.377.715.548.680.650 Immunoglobulin Fab Fragments 65
D12.776.377.715.548.680.650.125 Abciximab 14
D12.776.377.715.548.680.650.250 Certolizumab Pegol 47
D12.776.377.715.548.680.650.500 Immunoglobulin Variable Region 36
D12.776.377.715.548.680.650.750 Tuftsin 5